化聚乙烯胺和化胆酸脂质复杂系统,有效地将mRNA输送到深层瘤组织
Shengran Li1, Meiying Lv1, Weikang Mei2
1Key Laboratory of Polyoxometalate and Reticular Material Chemistry of Ministry of Education, School of Chemistry, Northeast Normal University, Changchun 130024, China.
Biomacromolecules
|July 29, 2024
概括
这项研究开发了一种新的化复合载体 (FPEI-FCP),用于有效地将mRNA输送到深层瘤组织. 优化的载体显著提高了瘤向和治疗乳腺癌治疗的疗效.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 有效的mRNA输送到深层疾病组织是治疗学中的一个主要障碍.
- 化聚合物为药物输送应用提供独特的特性.
研究的目的:
- 开发一种新型的复合输送系统,用于增强mRNA向深层瘤组织的目标.
- 在乳腺癌模型中评估FPEI-FCP载体对mRNA传递的疗效.
主要方法:
- 化聚乙烯胺 (FPEI) 与化胆酸盐 (FCP) 脂质的结合,产生mRNA载体.
- 为载体性能优化N/F原子比和FCP含量.
- 在4T1乳腺瘤模型中对瘤向,深度输送和治疗疗效的体内评估.
主要成果:
- 优化的mRNA@FPEI-FCP载体在深层瘤区域显示出显著的循环和积累.
- 与对照组相比,实现了瘤向的3.94倍增加和深度输送的3.0倍增加.
- IL-2 mRNA输送导致91.9%的瘤抑制, IL-2水平升高,CD4+ T细胞透率增加,没有副作用.
结论:
- FPEI-FCP复合系统显示了强大且有针对性的mRNA输送到深层瘤组织.
- 这种新型载体有望改善基于mRNA的癌症治疗方法.
- 对用于深层组织输送的化复合材料系统进行进一步的研究是有必要的.
相关概念视频
Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
Regulated mRNA Transport
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing specific...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


